These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 177297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Free and conjugated dihydroxyphenylacetic acid: effect of alterations in impulse flow in rat neostriatum and frontal cortex.
    Elchisak MA, Murrin LC, Roth RH, Maas JW.
    Psychopharmacol Commun; 1976; 2(5-6):411-20. PubMed ID: 193154
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Dihydroxyphenylacetic acid concentrations in the intermediate lobe and neural lobe of the posterior pituitary gland as an index of tuberohypophysial dopaminergic neuronal activity.
    Lindley SE, Gunnet JW, Lookingland KJ, Moore KE.
    Brain Res; 1990 Jan 01; 506(1):133-8. PubMed ID: 2302550
    [Abstract] [Full Text] [Related]

  • 5. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 6. Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex.
    Elchisak MA, Maas JW, Roth RH.
    Eur J Pharmacol; 1977 Feb 21; 41(4):369-78. PubMed ID: 844481
    [Abstract] [Full Text] [Related]

  • 7. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
    Beart PM, Gundlach AL.
    Br J Pharmacol; 1980 Jun 21; 69(2):241-7. PubMed ID: 6108139
    [Abstract] [Full Text] [Related]

  • 8. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P.
    J Pharm Pharmacol; 1987 Feb 21; 39(2):127-9. PubMed ID: 2881997
    [Abstract] [Full Text] [Related]

  • 9. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr 21; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 10. Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons.
    Di Giulio AM, Groppetti A, Cattabeni F, Galli CL, Maggi A, Algeri S, Ponzio F.
    Eur J Pharmacol; 1978 Nov 15; 52(2):201-7. PubMed ID: 729633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo voltammetric determination of the kinetics of dopamine metabolism in the rat.
    Michael AC, Justice JB, Neill DB.
    Neurosci Lett; 1985 May 23; 56(3):365-9. PubMed ID: 4022449
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T, Mizuno Y, Nagatsu T, Yoshida M.
    Neurosci Lett; 1988 Oct 17; 92(3):321-4. PubMed ID: 3200488
    [Abstract] [Full Text] [Related]

  • 14. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
    Wuerthele SM, Friedle NM, Moore KE.
    J Neural Transm; 1979 Oct 17; 45(2):117-27. PubMed ID: 469523
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 16. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1976 Jun 08; 37(2):249-55. PubMed ID: 954808
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec 08; 296(1):5-14. PubMed ID: 13315
    [Abstract] [Full Text] [Related]

  • 18. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
    Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ.
    Eur J Pharmacol; 1993 Mar 16; 233(1):135-42. PubMed ID: 8472742
    [Abstract] [Full Text] [Related]

  • 19. Effects of chronic electrode implantation on dopaminergic neurons in vivo.
    McCown TJ, Napier TC, Breese GR.
    Pharmacol Biochem Behav; 1986 Jul 16; 25(1):63-9. PubMed ID: 3018796
    [Abstract] [Full Text] [Related]

  • 20. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ.
    Eur J Pharmacol; 1976 Sep 16; 39(1):33-40. PubMed ID: 964303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.